Carnegie Investment Counsel’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.3K | Buy |
+31,000
| New | +$53.3K | ﹤0.01% | 538 |
|
|
2025
Q1 | – | Sell |
-27,000
| Closed | -$200K | – | 501 |
|
|
2024
Q4 | $200K | Hold |
27,000
| – | – | 0.01% | 449 |
|
|
2024
Q3 | $254K | Hold |
27,000
| – | – | 0.01% | 418 |
|
|
2024
Q2 | $217K | Sell |
27,000
-400
| -1% | -$3.21K | 0.01% | 444 |
|
|
2024
Q1 | $406K | Hold |
27,400
| – | – | 0.01% | 385 |
|
|
2023
Q4 | $223K | Buy |
27,400
+4,000
| +17% | +$32.5K | 0.01% | 457 |
|
|
2023
Q3 | $106K | Buy |
23,400
+11,000
| +89% | +$50.1K | ﹤0.01% | 477 |
|
|
2023
Q2 | $87.3K | Buy |
+12,400
| New | +$87.3K | ﹤0.01% | 490 |
|
|
2021
Q4 | – | Sell |
-21,250
| Closed | -$524K | – | 507 |
|
|
2021
Q3 | $524K | Sell |
21,250
-3,000
| -12% | -$74K | 0.02% | 317 |
|
|
2021
Q2 | $631K | Buy |
24,250
+200
| +0.8% | +$5.2K | 0.02% | 297 |
|
|
2021
Q1 | $761K | Sell |
24,050
-2,000
| -8% | -$63.3K | 0.03% | 272 |
|
|
2020
Q4 | $1.21M | Buy |
+26,050
| New | +$1.21M | 0.05% | 218 |
|